How do you approach buprenorphine dosing and titration in older adults with opioid use disorder?  

Older adults may have increased sensitivity to medications, higher rates of medical comorbidity, and greater risk of sedation or falls. Do you modify your approach to initial dosing, titration speed, or target dose in patients over 65? Are there particular side effects you monitor more closely in this population?